Literature DB >> 32643304

Clinical, radiological, and genetic characteristics in patients with Huntington's disease in a Taiwanese cohort.

Szu-Ju Chen1,2, Bo-Chin Lee3, Ni-Chung Lee4, Yin-Hsiu Chien4, Wuh-Liang Hwu4, Chin-Hsien Lin1.   

Abstract

Characteristics of Huntington's disease (HD) differ among various ethnicities. Few studies have explored the relationship between phenotypes and genotypes of HD in Asians. We evaluated the relationship between integrated clinical and imaging phenotypes and genotypes in a Taiwanese HD cohort, enrolling 123 HD patients genetically diagnosed between August 1994 and February 2019. The clinical presentations and brain magnetic resonance imaging characteristics were analyzed from 67 patients and examined the correlation with genetic findings. Chorea was the most common initial manifestation (66.1%), especially in patients with late-onset disease (onset age > 60 years old), followed by psychiatric symptoms (25%) and cognitive impairment (14.3%). Compared to patients with adult-onset HD, the prevalence of parkinsonism was significantly higher in juvenile-onset HD patients (onset age < 20 years old, p = .007). Disease burden, which was measured by CAG repeats and age, was significantly associated with atrophy in caudate nucleus (p = .004), followed by putamen (p = .029), nucleus accumbens (p = .002), thalamus (p = .003), and total cortical volume (p = .001) after correcting for total intracranial volume. Our findings, that provided the first series of Taiwanese HD patients, delineated the clinical, radiological, and genetic characteristics in Asian HD patients.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  Huntington's disease; brain imaging; phenotype

Mesh:

Year:  2020        PMID: 32643304     DOI: 10.1002/ajmg.b.32810

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  1 in total

Review 1.  Nucleus accumbens atrophy in Parkinson's disease (Mavridis' atrophy): 10 years later.

Authors:  Ioannis N Mavridis; Efstratios-Stylianos Pyrgelis
Journal:  Am J Neurodegener Dis       Date:  2022-06-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.